日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharomyces cerevisiae Uncharacterized protein YIL152W (YIL152W) CSB-YP334717SVG
CSB-EP334717SVG
CSB-BP334717SVG
CSB-MP334717SVG
CSB-EP334717SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein MLP2 (MLP2), partial CSB-YP334718SVG
CSB-EP334718SVG
CSB-BP334718SVG
CSB-MP334718SVG
CSB-EP334718SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YIL141W (YIL141W) CSB-YP334719SVG
CSB-EP334719SVG
CSB-BP334719SVG
CSB-MP334719SVG
CSB-EP334719SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Cell morphogenesis protein PAG1 (TAO3), partial CSB-YP334720SVG
CSB-EP334720SVG
CSB-BP334720SVG
CSB-MP334720SVG
CSB-EP334720SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Quinidine resistance protein 1 (QDR1), partial CSB-YP334721SVG
CSB-EP334721SVG
CSB-BP334721SVG
CSB-MP334721SVG
CSB-EP334721SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Histidine protein methyltransferase 1 (HPM1) CSB-YP334722SVG
CSB-EP334722SVG
CSB-BP334722SVG
CSB-MP334722SVG
CSB-EP334722SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae DBF2 kinase activator protein MOB1 (MOB1) CSB-YP334723SVG
CSB-EP334723SVG
CSB-BP334723SVG
CSB-MP334723SVG
CSB-EP334723SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Transcriptional repressor XBP1 (XBP1), partial CSB-YP334724SVG
CSB-EP334724SVG
CSB-BP334724SVG
CSB-MP334724SVG
CSB-EP334724SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Homoisocitrate dehydrogenase, mitochondrial (LYS12) CSB-YP334725SVG
CSB-EP334725SVG
CSB-BP334725SVG
CSB-MP334725SVG
CSB-EP334725SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein ICE2 (ICE2), partial CSB-YP334726SVG
CSB-EP334726SVG
CSB-BP334726SVG
CSB-MP334726SVG
CSB-EP334726SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Phosphopantothenate--cysteine ligase CAB2 (CAB2) CSB-YP334727SVG
CSB-EP334727SVG
CSB-BP334727SVG
CSB-MP334727SVG
CSB-EP334727SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae D-3-phosphoglycerate dehydrogenase 2 (SER33) CSB-YP334728SVG
CSB-EP334728SVG
CSB-BP334728SVG
CSB-MP334728SVG
CSB-EP334728SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitochondria fission 1 protein (FIS1), partial CSB-YP334729SVG
CSB-EP334729SVG
CSB-BP334729SVG
CSB-MP334729SVG
CSB-EP334729SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Transcription factor VHR1 (VHR1), partial CSB-YP334730SVG
CSB-EP334730SVG
CSB-BP334730SVG
CSB-MP334730SVG
CSB-EP334730SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae 60S ribosomal protein L34-B (RPL34B) CSB-YP334731SVG
CSB-EP334731SVG
CSB-BP334731SVG
CSB-MP334731SVG
CSB-EP334731SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae [Pyruvate dehydrogenase [lipoamide]] kinase, mitochondrial (PKP1) CSB-YP334732SVG
CSB-EP334732SVG
CSB-BP334732SVG
CSB-MP334732SVG
CSB-EP334732SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Pheromone-regulated membrane protein 3 (PRM2), partial CSB-YP334733SVG1
CSB-EP334733SVG1
CSB-BP334733SVG1
CSB-MP334733SVG1
CSB-EP334733SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Ubiquitin-like-specific protease 2 (ULP2), partial CSB-YP334734SVG
CSB-EP334734SVG
CSB-BP334734SVG
CSB-MP334734SVG
CSB-EP334734SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YIL025C (YIL025C) CSB-YP334735SVG
CSB-EP334735SVG
CSB-BP334735SVG
CSB-MP334735SVG
CSB-EP334735SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein FAF1 (FAF1) CSB-YP334736SVG
CSB-EP334736SVG
CSB-BP334736SVG
CSB-MP334736SVG
CSB-EP334736SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×